Asymchem Laboratories Co., Ltd. has officially inaugurated its new European development and pilot manufacturing site at Discovery Park in Sandwich, Kent, U.K.
 
The former Pfizer small molecule facilities now employ 70 team members on-site in both the R&D labs and the API pilot plant, many of whom are legacy Pfizer employees. Additional hires are planned through to the end of the year as the pilot plant ramps up operations.
 
Building on a foundation of utilizing innovative technologies to enable smarter, greener, and cost-effective solutions to support manufacture, Asymchem will add additional capabilities on-site. Advanced equipment for the manufacture of peptides and oligonucleotides, as well as sustainability capabilities for continuous flow and biocatalysis, will be added by 2025.
 
Dr. Hao Hong, Chairman, Founder, and CEO of Asymchem, who was present at the ribbon-cutting ceremony, said: “This is an exciting milestone for Asymchem to meet growing demand for pharma services and supply. We are continuing a long legacy of manufacturing excellence at Discovery Park, with the location in Kent being ideal for reaching our target markets in Europe.”